EP 1077685 A2 20010228 - NOVEL FORMULATION CONTAINING PAROXETINE
Title (en)
NOVEL FORMULATION CONTAINING PAROXETINE
Title (de)
NEUES ARZNEIMITTEL ENTHALTEND PAROXETIN
Title (fr)
NOUVELLE FORMULATION CONTENANT DE LA PAROXETINE
Publication
Application
Priority
- GB 9901522 W 19990513
- GB 9810180 A 19980513
Abstract (en)
[origin: WO9958116A2] Paroxetine hydrochloride, in a form other than the hemihydrate, which is formulated into capsules under conditions such there is no detectable conversion to hemihydrate during the manufacturing process.
IPC 1-7
IPC 8 full level
A61K 9/48 (2006.01); A61K 31/443 (2006.01); C07D 405/12 (2006.01); A61K 31/4525 (2006.01); A61P 25/24 (2006.01)
CPC (source: EP KR)
A61K 9/20 (2013.01 - KR); A61K 9/485 (2013.01 - EP); A61K 9/4858 (2013.01 - EP); A61K 31/4525 (2013.01 - EP); A61P 25/24 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9958116 A2 19991118; WO 9958116 A3 20000217; AP 2000001985 A0 20001231; AU 3941099 A 19991129; BG 105011 A 20010731; BR 9910402 A 20010109; CA 2331849 A1 19991118; CN 1309557 A 20010822; EA 200001173 A1 20010423; EP 1077685 A2 20010228; GB 9810180 D0 19980708; HU P0101931 A2 20020429; HU P0101931 A3 20021028; ID 27018 A 20010222; IL 139596 A0 20020210; JP 2002514593 A 20020521; KR 20010043545 A 20010525; NO 20005681 D0 20001110; NO 20005681 L 20001201; PL 344872 A1 20011119; SK 16972000 A3 20010611; TR 200003351 T2 20010321; ZA 200006465 B 20011109
DOCDB simple family (application)
GB 9901522 W 19990513; AP 2000001985 A 19990513; AU 3941099 A 19990513; BG 10501100 A 20001130; BR 9910402 A 19990513; CA 2331849 A 19990513; CN 99808548 A 19990513; EA 200001173 A 19990513; EP 99922303 A 19990513; GB 9810180 A 19980513; HU P0101931 A 19990513; ID 20002329 A 19990513; IL 13959699 A 19990513; JP 2000547967 A 19990513; KR 20007012660 A 20001113; NO 20005681 A 20001110; PL 34487299 A 19990513; SK 16972000 A 19990513; TR 200003351 T 19990513; ZA 200006465 A 20001109